ScoreWhy is Jinyu Bio-Technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 6.64%
- The company has been able to generate a Return on Capital Employed (avg) of 6.64% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -1.07% and Operating profit at -166.78% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 303.08 MM
- CASH AND EQV(HY) Lowest at CNY 2,484.98 MM
4
With ROE of 0.68%, it has a expensive valuation with a 1.93 Price to Book Value
- Over the past year, while the stock has generated a return of 113.02%, its profits have fallen by -87.5%
- At the current price, the company has a high dividend yield of 0.3
5
Market Beating Performance
- The stock has generated a return of 113.02% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jinyu Bio-Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jinyu Bio-Technology Co., Ltd.
46.48%
1.93
44.92%
China Shanghai Composite
16.78%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.20%
EBIT Growth (5y)
-58.57%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.25
Tax Ratio
20.41%
Dividend Payout Ratio
40.39%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.64%
ROE (avg)
5.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
129
Industry P/E
Price to Book Value
2.43
EV to EBIT
2073.35
EV to EBITDA
60.52
EV to Capital Employed
2.87
EV to Sales
8.62
PEG Ratio
3.01
Dividend Yield
0.25%
ROCE (Latest)
0.14%
ROE (Latest)
1.89%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET PROFIT(HY)
At CNY 24.01 MM has Grown at 78.44%
RAW MATERIAL COST(Y)
Fallen by -19.03% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 1.88 times
-3What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 325.64 MM
Here's what is working for Jinyu Bio-Technology Co., Ltd.
Net Profit
At CNY 24.01 MM has Grown at 78.44%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Debtors Turnover Ratio
Highest at 1.88 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -19.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jinyu Bio-Technology Co., Ltd.
Operating Cash Flow
Lowest at CNY 325.64 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
